Abba David Poliakoff's most recent trade in Champions Oncology Inc was a trade of 10,000 Common Stock done at an average price of $5.4 . Disclosure was reported to the exchange on Jan. 19, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | Abba David Poliakoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.43 per share. | 19 Jan 2021 | 10,000 | 90,147 (0%) | 0% | 5.4 | 54,300 | Common Stock |
| Champions Oncology Inc | Abba David Poliakoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.21 per share. | 19 Jan 2021 | 10,000 | 80,147 (0%) | 0% | 3.2 | 32,100 | Common Stock |
| Champions Oncology Inc | Abba David Poliakoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 10,000 | 0 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Abba David Poliakoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 10,000 | 0 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Abba David Poliakoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 10,000 | 0 | - | - | Option to purchase Common Stock | |
| Champions Oncology Inc | Abba David Poliakoff | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.59 per share. | 19 Jan 2021 | 10,000 | 70,147 (0%) | 0% | 1.6 | 15,900 | Common Stock |
| Champions Oncology Inc | Abba David Poliakoff | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.53 per share. | 19 Jan 2021 | 8,873 | 81,274 (0%) | 0% | 11.5 | 102,306 | Common Stock |
| Champions Oncology Inc | Abba David Poliakoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2020 | 2,500 | 2,500 | - | - | Option to purchase Common Stock |